Acro Biomedical (ACBM) Current Leases (2019 - 2025)
Acro Biomedical (ACBM) posted Current Leases of $13651.0 for Q2 2025, down 24.2% on a QoQ basis from $18009.0 in Q1 2025, and down 47.71% year-over-year from $26105.0 in Q2 2024.
Powered by 
Analysis
Acro Biomedical (ACBM) Current Leases (2019 - 2025) Analysis & Trends
Acro Biomedical has reported Current Leases for 7 years, with the latest figure at $13651.0 in Q2 2025.
- On a quarterly basis, Current Leases fell 47.71% year-over-year to $13651.0 in Q2 2025; TTM through Jun 2025 was $13651.0, a 47.71% decrease from a year earlier, with the FY2024 full-year figure at $26898.0, up 6.17% from the prior year.
- Current Leases was $13651.0 for Q2 2025 at Acro Biomedical, down from $18009.0 in the prior quarter.
- The five-year high for Current Leases was $26898.0 in Q4 2024, with the low at $6526.0 in Q3 2023.
- Average Current Leases over 5 years is $20904.6, with a median of $24713.0 recorded in 2021.
- The sharpest annual moves came in 2023 and 2024: Current Leases slumped 74.37% in 2023, then surged 306.05% in 2024.
- Over 5 years, Current Leases stood at $24713.0 in 2021, then gained by 4.07% to $25719.0 in 2022, then retreated by 1.49% to $25335.0 in 2023, then grew by 6.17% to $26898.0 in 2024, then plunged by 49.25% to $13651.0 in 2025.
- The last three Current Leases figures came in at $13651.0 (Q2 2025), $18009.0 (Q1 2025), and $26898.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | - |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | - |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | - |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 199.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 6.91 Mn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | - |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 36.00 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | - |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 13,173.00 |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 13,651.00 |
| Mar 31, 2025 | 18,009.00 |
| Dec 31, 2024 | 26,898.00 |
| Sep 30, 2024 | 26,499.00 |
| Jun 30, 2024 | 26,105.00 |
| Mar 31, 2024 | 23,402.00 |
| Dec 31, 2023 | 25,335.00 |
| Sep 30, 2023 | 6,526.00 |
| Jun 30, 2023 | 12,988.00 |
| Mar 31, 2023 | 19,385.00 |
| Dec 31, 2022 | 25,719.00 |
| Sep 30, 2022 | 25,464.00 |
| Jun 30, 2022 | 25,211.00 |
| Mar 31, 2022 | 24,961.00 |
| Dec 31, 2021 | 24,713.00 |
| Jun 30, 2021 | 12,154.00 |
| Mar 31, 2021 | 18,358.00 |
| Sep 30, 2020 | 26,847.00 |
| Jun 30, 2020 | 26,602.00 |
| Mar 31, 2020 | 26,359.00 |